neuromuscular stimulation and mindfulnessneuromuscular electrical stimulation
neuromuscular stimulation and mindfulness: Receive neuromuscular stimulation and mindfulness breathing; the experimental group participants will receive neuromuscular electrical stimulation with Mindfulness.
neuromuscular electrical stimulation: participants in the control group perceived neuromuscular electrical stimulation
Study summary
It is an interventional study in which 60 stroke patients were estimated to enroll according to random allocation and divided into two groups. The experimental group will receive neuromuscular stimulation and mindfulness , while the control group will receive neuromuscular stimulation only.
Eligibility
Sex
ALL
Min age
50 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* The subject selection will be according to the following criteria:
* All Patients of this study will be diagnosed as stroke and the diagnosis will be confirmed by computed tomography or MRI (El-Tamawy et al., 2021).
* Age of patients will be ranged from 50 to 65years (males and females).
* All patients will be hemodynamically stable.
* Patients with good cognition that enables them to understand the requirements of the study.
Exclusion Criteria:
* • The potential participants will be excluded if they meet one of the following criteria:
* Patients who cannot follow instructions as sensory aphasia, blindness, dementia, and deafness.
* Patients with any orthopedic, neurological, or chest disorders that affect trunk muscles control or cause respiratory disorders as COPD.
* Patients with cognitive and psychiatric disorders.
* Patients with unstable cardiovascular conditions.
* Patients with contraindications to neuro electrical stimulation as:
* Cardiac pace maker.
* Acute abdominal surgery.
Primary outcome measure(s)
ventilatory function — 12 weeks By a spirometer, forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), the ratio of forced vital capacity to forced expiratory volume (FEV1/FVC), and peak expiratory flow will be measured.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.